scholarly journals PCN50 COST-MINIMIZATION ANALYSIS OF ERLOTINIB VERSUS DOCETAXEL OR PEMETREXED AS A SECOND-LINE TRETAMENT OF ADVANCED NON-SMALL LUNG CANCER (NSCLC) IN THE CONDITIONS OF THE CZECH REPUBLIC

2008 ◽  
Vol 11 (6) ◽  
pp. A475 ◽  
Author(s):  
E Suchankova ◽  
T Doležal
Keyword(s):  
Lung Cancer ◽  
Czech Republic ◽  
Cost Minimization ◽  
Second Line ◽  
The Czech Republic ◽  
Cost Minimization Analysis

scholarly journals PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

2011 ◽  
Vol 14 (7) ◽  
pp. A440 ◽  
Author(s):  
C. Laurendeau ◽  
C. Chouaid ◽  
V. Florentin ◽  
V. Duchon D'engenières ◽  
B. Detournay
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Cost Minimization ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Cost Minimization Analysis ◽  
Line Chemotherapy

Epidemiology of lung cancer in the Czech Republic 1970–1996

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 231
Author(s):  
M Marel ◽  
Z Skacel ◽  
I Spasova
Keyword(s):  
Lung Cancer ◽  
Czech Republic ◽  
The Czech Republic

scholarly journals 1405P Survival of patients with non-small cell lung cancer and exon 20 insertion mutation from the Czech Republic

2020 ◽  
Vol 31 ◽  
pp. S890
Author(s):  
J. Skrickova ◽  
M. Pesek ◽  
P. Opalka ◽  
L. Koubkova ◽  
M. Zemanová ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Czech Republic ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Insertion Mutation ◽  
Small Cell Lung ◽  
The Czech Republic ◽  
Exon 20

P-695 Surgical treatment of lung cancer in university hospitals in the Czech Republic in the period 1970–2002

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S267
Author(s):  
Miloslav Marel ◽  
Zdenek Skacel ◽  
Irena Spasova ◽  
Boris Stastny ◽  
L. Melinova
Keyword(s):  
Lung Cancer ◽  
Czech Republic ◽  
Surgical Treatment ◽  
University Hospitals ◽  
The Czech Republic
Sign in / Sign up

Export Citation Format

Share Document